Neuronal cholesterol esterification by ACAT1 in Alzheimer's disease

IUBMB Life

Volumn 62, Issue 4, 2010, Pages 261-267

  Chang, Ta Yuan ^a   Chang, Catherine C Y ^a   Bryleva, Elena ^a   Rogers, Maximillian A ^a   Murphy, Stephanie R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

ACAT1; Alzheimer's disease; Cholesterol metabolism; Oxysterols

Indexed keywords

AMYLOID PRECURSOR PROTEIN; AVASIMIBE; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; CHOLESTEROL DERIVATIVE; CHOLESTEROL ESTER; CP 113 818; CP 113818; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OXYSTEROL; PROTEIN ACAT 1; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BIOSYNTHESIS; CHOLESTEROL ESTERIFICATION; CHOLESTEROL METABOLISM; ENZYME INHIBITION; GENE MUTATION; HUMAN; IN VIVO STUDY; NONHUMAN; PROTEIN EXPRESSION; REVIEW; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CHOLESTEROL; ESTERIFICATION; HUMANS; HYDROXYCHOLESTEROLS; LIPID METABOLISM; MICE; NEURODEGENERATIVE DISEASES; NEURONS; RISK;

EID: 77951118238     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.305     Document Type: Review

References (82)

1. Goldstein, J. L. and Brown, M. S. (1990) Regulation of the mevalonate pathway. Nature 343, 425-430.
2. Goldstein, J. L., DeBose-Boyd, R. A., and Brown, M. S. (2006) Protein sensors for membrane sterols. Cell 124, 35-46.
3. Maxfield, F. R. and Menon, A. K. (2006) Intracellular sterol transport and distribution. Curr. Opin. Cell Biol. 18, 379-385.
4. Chang, T. Y., Chang, C. C., Ohgami, N., and Yamauchi, Y. (2006) Cholesterol sensing, trafficking, and esterification. Annu. Rev. Cell Dev. Biol. 22, 129-157.
5. Urano, Y., Watanabe, H., Murphy, S. R., Shibuya, Y., Geng, Y., Peden, A. A., Chang, C. C., and Chang, T. Y. (2008) Transport of LDL-derived cholesterol from the NPC1 compartment to the ER involves the trans-Golgi network and the SNARE protein complex. Proc. Natl. Acad. Sci. USA 105, 16513-16518.
6. Warner, G. J., Stoudt, G., Bamberger, M., Johnson, W. J., and Rothblat, G. H. (1995) Cell toxicity induced by inhibition of acyl coenzyme A:cholessterol acyltransferase and accumulation of unesterified cholesterol. J. Biol. Chem. 270, 5772-5778.
7. Tabas, I. (2002) Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J. Clin. Invest. 110, 905-911.
8. Russell, D. W. (2000) Oxysterol biosynthetic enzymes. Biochim. Biophys. Acta 1529, 126-135.
9. Karasinska, J. M., Rinninger, F., Lutjohann, D., Ruddle, P., Franciosi, S., Kruit, J. K., Singaraja, R. R., Hirsch-Reinshagen, V., Fan, J., Brunham, L. R., Bissada, N., Ramakrishnan, R., Wellington, C. L., Parks, J. S., and Hayden, M. R. (2009) Specific loss of brain ABCA1 increases brain cholesterol uptake and influences neuronal structure and function. J. Neurosci. 29, 3579-3589.
10. Spencer, T. A., Gayen, A. K., Phirwa, S., Nelson, J. A., Taylor, F. R., Kandutsch, A. A., and Erickson, S. K. (1985) 24(S),25-Epoxycholesterol: Evidence consistent with a role in the regulation of hepatic cholesterogenesis. J. Biol. Chem. 260, 13391-13394.
11. Wong, J., Quinn, C. M., Guillemin, G., and Brown, A. J. (2007) Primary human astrocytes produce 24(S),25-epoxycholesterol with implications for brain cholesterol homeostasis. J. Neurochem. 103, 1764-1773.
12. Brown, A. J. and Jessup, W. (2009) Oxysterols: sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis. Mol. Aspects Med. 30, 111-122.
13. Chang, C. C. Y., Huh, H. Y., Cadigan, K. M., and Chang, T. Y. (1993) Molecular cloning and functional expression of human acyl-coenzyme A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells. J. Biol. Chem. 268, 20747-20755.
14. Yang, H., Bard, M., Bruner, D. A., Gleeson, A., Deckelbaum, R. J., Alijinovic, G., Pohl, T. M., Rothstein, R., and Sturley, S. L. (1996) Sterol esterification in yeast: a two-gene process. Science 272, 1353-1356.
15. Oelkers, P., Behari, A., Cromley, D., Billheimer, J. T., and Sturley, S. L. (1998) Characterization of two human genes encoding acyl coenzyme A: cholesterol acyltransferase-related enzymes. J. Biol. Chem. 273, 26765-26771.
16. Yu, C., Kennedy, N. J., Chang, C. C. Y., and Rothblatt, J. A. (1996) Molecular cloning and characterization of two isoforms of Saccharomyces cerevisiae acyl-coA:sterol acyltransferase. J. Biol. Chem. 271, 24157-24163.
17. Cases, S., Novak, S., Zheng, Y. W., Myers, H., Lear, S. R., Sande, E., Welch, C. B., Lusis, A. J., Spencer, T. A., Krause, B. R., Erickson, S. K., and Farese, R. V., Jr. (1998) ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase. Its cloning, expression, and characterization. J. Biol. Chem. 273, 26755-26764.
18. Anderson, R. A., Joyce, C., Davis, M., Reagan, J. W., Clark, M., Shelness, G. S., and Rudel, L. L. (1998) Identification of a form of acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates. J. Biol. Chem. 273, 26747-26754.
19. Buhman, K. F., Accada, M., and Farese, R. V. Jr. (2000) Mammalian acyl-CoA:cholesterol acyltransferases. Biochim. Biophys. Acta 1529, 142-154.
20. Hofmann, K. (2000) A superfamily of membrane-bound O-acyltransferases with implications for Wnt signaling. Trends Biochem. Sci. 25, 111-112.
21. Guo, Z. Y., Lin, S., Heinen, J. A., Chang, C. C., and Chang, T. Y. (2005) The active site His-460 of human acyl-coenzyme A:cholesterol acyltransferase 1 resides in a hitherto undisclosed transmembrane domain. J. Biol. Chem. 280, 37814-37826.
22. Yang, J., Brown, M. S., Liang, G., Grishin, N. V., and Goldstein, J. L. (2008) Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132, 387-396.
23. Ray, W. J., Ashall, F., and Goate, A. M. (1998) Molecular pathogenesis of sporadic and familial forms of Alzheimer's disease. Mol. Med. Today 4, 151-157.
24. Gutierrez, J. A., Solenberg, P. J., Perkins, D. R., Willency, J. A., Knierman, M. D., Jin, Z., Witcher, D. R., Luo, S., Onyia, J. E., and Hale, J. E. (2008) Ghrelin octanoylation mediated by an orphan lipid transferase. Proc. Natl. Acad. Sci. USA 105, 6320-6325.
25. Shindou, H. and Shimizu, T. (2009) Acyl-CoA:lysophospholipid acyltransferases. J. Biol. Chem. 284, 1-5.
26. Rudel, L., Lee, R., and Cockman, T. (2001) Structure, function, and regulation of ACAT. Curr. Opin. Lipidol. 12, 121-127.
27. Chang, T. Y., Li, B. L., Chang, C. C., and Urano, Y. (2009) Acyl-coenzyme A:cholesterol acyltransferases. Am. J. Physiol. Endocrinol. Metab. 297, E1-E9.
28. Chang, C. C. Y., Sakashita, N., Ornvold, K., Lee, O., Chang, E. T., Dong, R., Lin, S., Lee, C. Y., Strom, S. C., Kashyap, R., Fung, J. J., Farese, R. V., Jr., Patoiseau, J. F., Delhon, A., and Chang, T. Y. (2000) Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine. J. Biol. Chem. 275, 28083-28092.
29. Parini, P., Davis, M., Lada, A. T., Erickson, S. K., Wright, T. L., Gustafsson, U., Sahlin, S., Einarsson, C., Eriksson, M., Angelin, B., Tomoda, H., Omura, S., Willingham, M. C., and Rudel, L. L. (2004) ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver. Circulation 110, 2017-2023.
30. Song, B. L., Wang, C. H., Yao, X. M., Yang, L., Zhang, W. J., Wang, Z. Z., Zhao, X. N., Yang, J. B., Qi, W., Yang, X. Y., Inoue, K., Lin, Z. X., Zhang, H. Z., Kodama, T., Chang, C. C., Liu, Y. K., Chang, T. Y., and Li, B. L. (2006) Human acyl-CoA:cholesterol acyltransferase 2 gene expression in intestinal Caco-2 cells and in hepatocellular carcinoma. Biochem. J. 394, 617-626.
31. Lin, S., Lu, X., Chang, C. C. Y., and Chang, T. Y. (2003) Human acyl-coenzyme A: cholesterol acyltransferase 2 (hACAT2) expressed in Chinese hamster ovary cells: membrane topology and active site location. Mol. Biol. Cell 14, 2447-2460.
32. Chang, C. C. Y., Lee, C. Y. G., Chang, E. T., Cruz, J. C., Levesque, M. C., and Chang, T. Y. (1998) Recombinant human acyl-CoA:cholesterol acyltransferase 1 (ACAT1) purified to essential homogeneity utilizes cholesterol in mixed micelles or vesicles in a highly cooperative manner. J. Biol. Chem. 273, 35132-35141.
33. Cheng, D., Chang, C. C., Qu, X., and Chang, T. Y. (1995) Activation of acyl-coenzyme A:cholesterol acyltransferase by cholesterol or by oxysterol in a cell-free system. J. Biol. Chem. 270, 685-695.
34. Zhang, Y., Yu, C., Liu, J., Spencer, T. A. J., Chang, C. C. Y., and Chang, T. Y. (2003) Cholesterol is superior to 7-ketocholesterol or 7alpha-hydroxycholesterol as an allosteric activator for acyl-coenzyme A: cholesterol acyltransferase 1. J. Biol. Chem. 278, 11642-11647.
35. Liu, J., Chang, C. C., Westover, E. J., Covey, D. F., and Chang, T. Y. (2005) Investigating the allosterism of acyl coenzyme A: cholesterol acyltransferase (ACAT) by using various sterols: In vitro and intact cell studies. Biochem. J. 391, 389-397.
36. Miyazaki, A., Sakashita, N., Lee, O., Takahashi, K., Horiuchi, S., Hakamata, H., Morganelli, P. M., Chang, C. C., and Chang, T. Y. (1998) Expression of ACAT1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages. Arterioscler. Thromb. Vasc. Biol. 18, 1568-1574.
37. Bryleva, E. Y., Rogers, M. A., Chang, C. C. Y., Buen, F., Harris, B. T., Rousselet, E., Seidah, N. G., Oddo, S., LaFerla, F. M., Spencer, T. A., Hickey, W. F., and Chang, T. Y. ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in AD mice. Proc. Natl. Acad. Sci. USA, in press.
38. Hardy, J. and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
39. Lee, V. M. and Trojanowski, J. Q. (2006) Progress from Alzheimer's tangles to pathological tau points towards more effective therapies now. J. Alzheimers Dis. 9, 257-262.
40. Zheng, H. and Koo, E. H. (2006) The amyloid precursor protein: beyond amyloid. Mol. Neurodegener. 1, 5.
41. Lee, V. M., Giasson, B. I., and Trojanowski, J. Q. (2004) More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases. Trends Neurosci. 27, 129-134.
42. Thinakaran, G. and Koo, E. H. (2008) Amyloid precursor protein trafficking, processing, and function. J. Biol. Chem. 283, 29615-29619.
43. Strittmatter, W. J. and Roses, A. D. (1996) Apolipoprotein E and Alzheimer's disease. Annu. Rev. Neurosci. 19, 53-77.
44. Mahley, R. W., Weisgraber, K. H., and Huang, Y. (2006) Inaugural Article: Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc. Natl. Acad. Sci USA 103, 5644-5651.
45. Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., Holtzman, D. M., and Zlokovic, B. V. (2008) apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J. Clin. Invest. 118, 4002-4013.
46. Anstey, K. J., Lipnicki, D. M., and Low, L. F. (2008) Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am. J. Geriatr. Psychiatry 16, 343-354.
47. Wolozin, B. (2004) Cholesterol and the biology of Alzheimer's disease. Neuron 41, 7-10.
48. Jiang, Q., Lee, C. Y., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., Mann, K., Lamb, B., Willson, T. M., Collins, J. L., Richardson, J. C., Smith, J. D., Comery, T. A., Riddell, D., Holtzman, D. M., Tontonoz, P., and Landreth, G. E. (2008) ApoE promotes the proteolytic degradation of Abeta. Neuron 58, 681-693.
49. Wellington, C. L. (2004) Cholesterol at the crossroads: Alzheimer's disease and lipid metabolism. Clin. Genet. 66, 1-16.
50. Hartmann, T. (2001) Cholesterol, A beta and Alzheimer's disease. Trends Neurosci. 24, S45-S48.
51. Dietschy, J. M. and Turley, S. D. (2004) Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res. 45, 1375-1397.
52. Repa, J. J. and Mangelsdorf, D. J. (2000) The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu. Rev. Cell Dev. Biol. 16, 459-481.
53. Beaven, S. W. and Tontonoz, P. (2006) Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia. Annu. Rev. Med. 57, 313-329.
54. Wang, N., Yvan-Charvet, L., Lutjohann, D., Mulder, M., Vanmierlo, T., Kim, T. W., and Tall, A. R. (2008) ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain. FASEB J. 22, 1073-1082.
55. Tarr, P. T. and Edwards, P. A. (2008) ABCG1 and ABCG4 are coexpressed in neurons and astrocytes of the CNS and regulate cholesterol homeostasis through SREBP-2. J. Lipid Res. 49, 169-182.
56. Russell, D. W., Halford, R. W., Ramirez, D. M., Shah, R., and Kotti, T. (2009) Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain. Annu. Rev. Biochem. 78, 1017-1040.
57. Lutjohann, D., Breuer, O., Ahlborg, G., Nennesmo, I., Siden, A., Diczfalusy, U., and Bjorkhem, I. (1996) Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc. Natl. Acad. Sci. USA 93, 9799-9804.
58. Bjorkhem, I. (2006) Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J. Intern. Med. 260, 493-508.
59. Karu, K., Hornshaw, M., Woffendin, G., Bodin, K., Hamberg, M., Alvelius, G., Sjovall, J., Turton, J., Wang, Y., and Griffiths, W. J. (2007) Liquid chromatography-mass spectrometry utilizing multi-stage fragmentation for the identification of oxysterols. J. Lipid Res. 48, 976-987.
60. Lund, E. G., Xie, C., Kotti, T., Turley, S. D., Dietschy, J. M., and Russell, D. W. (2003) Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J. Biol. Chem. 278, 22980-22988.
61. Song, B. L., Javitt, N. B., and DeBose-Boyd, R. A. (2005) Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol. Cell Metab. 1, 179-189.
62. Wang, Y., Muneton, S., Sjovall, J., Jovanovic, J. N., and Griffiths, W. J. (2008) The effect of 24S-hydroxycholesterol on cholesterol homeostasis in neurons: quantitative changes to the cortical neuron proteome. J. Proteome Res. 7, 1606-1614.
63. Janowski, B. A., Grogan, M. J., Jones, S. A., Wisely, G. B., Kliewer, S. A., Corey, E. J., and Mangelsdorf, D. J. (1999) Structural requirements of ligands for the oxysterol liver X receptors LXRa and LXRB. Proc. Natl. Acad. Sci. USA 96, 266-271.
64. Brown, J., 3rd, Theisler, C., Silberman, S., Magnuson, D., Gottardi-Littell, N., Lee, J. M., Yager, D., Crowley, J., Sambamurti, K., Rahman, M. M., Reiss, A. B., Eckman, C. B., and Wolozin, B. (2004) Differential expression of cholesterol hydroxylases in Alzheimer's disease. J. Biol. Chem. 279, 34674-34681.
65. Heverin, M., Bogdanovic, N., Lutjohann, D., Bayer, T., Pikuleva, I., Bretillon, L., Diczfalusy, U., Winblad, B., and Bjorkhem, I. (2004) Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J. Lipid Res. 45, 186-193.
66. Venero, C. V. and Thompson, P. D. (2009) Managing statin myopathy. Endocrinol Metab. Clin. North Am. 38, 121-136.
67. Fassbender, K., Simons, M., Bergmann, C., Stroick, M., Lutjohann, D., Keller, P., Runz, H., Kuhl, S., Bertsch, T., von Bergmann, K., Hennerici, M., Beyreuther, K., and Hartmann, T. (2001) Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc. Natl. Acad. Sci. USA 98, 5856-5861.
68. Solomon, A. and Kivipelto, M. (2009) Cholesterol-modifying strategies for Alzheimer's disease. Expert Rev. Neurother. 9, 695-709.
69. Kovacs, T. (2009) Therapy of Alzheimer disease. Neuropsychopharmacol. Hung. 11, 27-33.
70. Evans, B. A., Evans, J. E., Baker, S. P., Kane, K., Swearer, J., Hinerfeld, D., Caselli, R., Rogaeva, E., St George-Hyslop, P., Moonis, M., and Pollen, D. A. (2009) Long-term statin therapy and CSF cholesterol levels: implications for Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 27, 519-524.
71. Hutter-Paier, B., Huttunen, H. J., Puglielli, L., Eckman, C. B., Kim, D. Y., Hofmeister, A., Moir, R. D., Domnitz, S. B., Frosch, M. P., Windisch, M., and Kovacs, D. M. (2004) The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease. Neuron 44, 227-238.
72. Huttunen, H. J., Peach, C., Bhattacharyya, R., Barren, C., Pettingell, W., Hutter-Paier, B., Windisch, M., Berezovska, O., and Kovacs, D. M. (2009) Inhibition of acyl-coenzyme A: cholesterol acyl transferase modulates amyloid precursor protein trafficking in the early secretory pathway. FASEB J. 23, 3819-3828.
73. Huttunen, H. J. and Kovacs, D. M. (2008) ACAT as a drug target for Alzheimer's disease. Neurodegener. Dis. 5, 212-214.
74. Yusuf, H. K. and Mozaffar, Z. (1979) Raised level of cholesterol esters in the brain of protein undernourished mice. J. Neurochem. 32, 273-275.
75. Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., and LaFerla, F. M. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39, 409-421.
76. Liu, B., Ramirez, C. M., Miller, A. M., Repa, J. J., Turley, S. D., and Dietschy, J. M. (2009) Cyclodextrin overcomes the transport defect in nearly every organ of the newborn or mature NPC1 mouse leading to excretion of the sequestered cholesterol as bile acid. J. Lipid Res.
77. Brown, A. J., Watts, G. F., Burnett, J. R., Dean, R. T., and Jessup, W. (2000) Sterol 27-hydroxylase acts on 7-ketocholesterol in human atherosclerotic lesions and macrophages in culture. J. Biol. Chem. 275, 27627-27633.
78. DeBose-Boyd, R. A. (2008) Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase. Cell Res. 18, 609-621.
79. Homan, R. and Hamelehle, K. L. (2001) Influence of membrane partitioning on inhibitors of membrane-bound enzymes. J. Pharm. Sci. 90, 1859-1867.
80. Bjorkhem, I. (2009) Are side-chain oxidized oxysterols regulators also in vivo? J. Lipid Res. 50 Suppl, S213-S218.
81. Halford, R. W. and Russell, D. W. (2009) Reduction of cholesterol synthesis in the mouse brain does not affect amyloid formation in Alzheimer's disease, but does extend lifespan. Proc. Natl. Acad. Sci. USA 106, 3502-3506.
82. Hudry, E., Van Dam, D., Kulik, W., De Deyn, P. P., Stet, F. S., Ahouansou, O., Benraiss, A., Delacourte, A., Bougneres, P., Aubourg, P., and Cartier, N. (2010) Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease. Mol. Ther. 18, 44-53.